相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cyanidin-3-O-Glucoside Ameliorates Lipopolysaccharide-Induced Injury Both In Vivo and In Vitro Suppression of NF-kappa B and MAPK Pathways
Ming-Ming Ma et al.
INFLAMMATION (2015)
Protein Kinase C Inhibitor, GF109203X Attenuates Osteoclastogenesis, Bone Resorption and RANKL-Induced NF-κB and NFAT Activity
Jun Yao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Relationship Between Oxidative Stress and Bone Mass in Obesity and Effects of Berry Supplementation on Bone Remodeling in Obese Male Mice: An Exploratory Study
Sang Gil Lee et al.
JOURNAL OF MEDICINAL FOOD (2015)
Triptolide inhibits osteoclast formation, bone resorption, RANKL-mediated NF-κB activation and titanium particle-induced osteolysis in a mouse model
Jianbin Huang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Choline Kinase β Mutant Mice Exhibit Reduced Phosphocholine, Elevated Osteoclast Activity, and Low Bone Mass
Jasreen Kular et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling
Zanjing Zhai et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo
Z. J. Zhai et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Delphinidin, One of the Major Anthocyanidins, Prevents Bone Loss through the Inhibition of Excessive Osteoclastogenesis in Osteoporosis Model Mice
Sawako Moriwaki et al.
PLOS ONE (2014)
SC-514, a selective inhibitor of IKKβ attenuates RANKL-induced osteoclastogenesis and NF-κB activation
Qian Liu et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Public Health Impact of Osteoporosis
Jane A. Cauley
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2013)
Loss of Protein Kinase C-δ Protects against LPS-Induced Osteolysis Owing to an Intrinsic Defect in Osteoclastic Bone Resorption
Ee Cheng Khor et al.
PLOS ONE (2013)
Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation
Estabelle S. M. Ang et al.
FEBS LETTERS (2011)
Mangiferin Attenuates Osteoclastogenesis, Bone Resorption, and RANKL-Induced Activation of NF-kappa B and ERK
Estabelle Ang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo
Kihyun Kim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Anthocyanin attenuates CD40-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced MAPK activation
Min Xia et al.
ATHEROSCLEROSIS (2009)
NF-κB modulators in osteolytic bone diseases
Jiake Xu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2009)
Myocyte Enhancer Factor 2 and Microphthalmia-associated Transcription Factor Cooperate with NFATc1 to Transactivate the V-ATPase d2 Promoter during RANKL-induced Osteoclastogenesis
HaoTian Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
PU.1 and NFATc1 mediate osteoclastic induction of the mouse β3 integrin promoter
Tania N. Crotti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Receptor activator of nuclear factor-κB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase
Jackie A. Fretz et al.
MOLECULAR ENDOCRINOLOGY (2008)
Particle-induced osteolysis in three-dimensional micro-computed tomography
Christian Wedemeyer et al.
CALCIFIED TISSUE INTERNATIONAL (2007)
A novel promoter regulates calcitonin receptor gene expression in human osteoclasts
Zhenxin Shen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2007)
Naturally occurring NF-κB inhibitors
Nguyen-Hai Nam
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis
Y Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits
B Jayaprakasam et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2005)
Potent lipid peroxidation inhibitors from Withania somnifera fruits
B Jayaprakasam et al.
TETRAHEDRON (2004)
Induction of apoptosis in two human leukemia cell lines as well as differentiation in human promyelocytic cells by cyanidin-3-O-β-glucopyranoside
C Fimognari et al.
BIOCHEMICAL PHARMACOLOGY (2004)
12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappa B activation
C Wang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells
H Hotokezaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
H Takayanagi et al.
DEVELOPMENTAL CELL (2002)
Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor
M Matsumoto et al.
FEBS LETTERS (2000)
Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-κB ligand
JK Xu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-κB ligand (RANKL)
M Matsumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength
M Chellaiah et al.
JOURNAL OF CELL BIOLOGY (2000)
分享论文
